Name: BBNX Balance Sheet - Beta Bionics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BBNX - Beta Bionics, Inc.

USD | NASDAQ | Healthcare

BBNX Balance Sheet - Beta Bionics Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022
Cash And Short Term Investments
Cash And Equivalents	31.6	30.4	26.6	-
Restricted Cash	0.1	-	-	-
Short Term Investments	187.5	73.1	70.2	-
Cash And Short Term Investments	219.1	103.6	96.7	-
Receivables
Accounts Receivable	17.1	12.0	4.4	-
Current Assets
Inventory	21.7	13.3	1.2	-
Prepaid Expenses	9.8	4.0	1.2	-
Other Current Assets	-	1.1	0.3	-
Non-Current Assets
Property, Plant & Equipment Gross	14.4	10.0	6.9	-
Accumulated Depreciation	5.8	5.3	4.4	-
Property,Plant & Equipment Net	8.6	4.8	2.5
Current Liabilities
Accounts Payable	5.0	2.9	1.2	-
Short Term Debt	-	-	-	-
Deferred Revenue Current	1.6	0.9	0.1	-
Non-Current Liabilities
Long Term Debt	-	-	-	-
Operating Lease Liabilities Non-Current	5.4	5.7	3.0	-
Deferred Revenue Non-Current	3.3	1.9	0.3
Common Equity
Common Stock	0.0	0.0	-	-
Additional Paid In Capital	657.1	51.3	26.4	-
Retained Earnings	(369.9)	(296.7)	(229.7)
Supplementary Data
Total Debt	-	-	-	-
Net debt	-	-	-	-
Working Capital	237.0	111.8	93.0	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q4 FY 22
Cash And Short Term Investments
Cash And Equivalents	30.2	31.6	38.5	35.1	42.5	30.4	17.5	13.0	22.1	-	-
Restricted Cash	0.1	0.1	-	-	-	-	-	-	-	-	-
Short Term Investments	169.3	187.5	190.2	214.6	189.0	73.1	-	-	-	-	-
Cash And Short Term Investments	199.5	219.1	228.7	249.7	231.5	103.6	17.5	13.0	22.1	-	-
Receivables
Accounts Receivable	15.8	17.1	11.5	11.4	9.1	12.0	-	-	-	-	-
Current Assets
Inventory	23.7	21.7	20.4	17.3	15.7	13.3	-	-	-	-	-
Prepaid Expenses	8.9	9.8	9.4
Non-Current Assets
Property, Plant & Equipment Gross	16.5	14.4	13.7	12.4	11.1	10.0	-	-	-	-	-
Accumulated Depreciation	6.3
Current Liabilities
Accounts Payable	2.3	5.0	4.5	3.4	3.5	2.9	-	-	-	-	-
Short Term Debt	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	5.1	5.4
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-	-
Additional Paid In Capital	663.2	657.1	650.9
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)